The global Infertility Market Size is increasing progressively, mainly due to the presence of proper regulatory frameworks that have helped assisted reproduction technologies to gain quick acceptance in developed as well as developing regions, globally. These fertility technologies have garnered tremendous popularity and, are perceiving an upsurge demand, worldwide. As a result, over the past couple of decades, the infertility market is garnering more attention on the global platform.
Considering the phenomenal accruals, the market is continuously gaining; Market Research Future (MRFR), in its recently published study report asserts that the global Infertility market is set to witness a sound growth by 2023, registering approximately 4.6% CAGR throughout the forecast period.
Major Players:
Key players leading the global infertility market include SCSA Diagnostics, Inc., Halotech DNA, Andrology Solutions, Androvia LifeSciences, Zydus Cadila Healthcare Ltd, Aetna Inc., EMD Serono, Inc., and Bayer Healthcare among others.
Global Infertility Market – Segments
For ease of understanding, the market has been segmented into five key dynamics: -
- By Sex : Males, Females and Unexplained.
- By Diagnosis: Men Diagnostic Tests (Semen Analysis, Genetic Testing, Testicular Biopsy, and other), Women Diagnostic Tests (Hysteroscopy, Laparoscopy, Ovulation Testing, Hysterosalpingography, and others.) and General Diagnostic Tests (Genetic Testing, Hormone Testing, Microscopic Analysis, Imaging, and others). Among other tests.
- By Drugs: Clomiphene Citrate, Letrozole, Serophene, and Hormone Treatment among others.
- By Techniques: Assisted Reproductive Technology (ART), Intrauterine Insemination, and Surgeries (Laparoscopic or Hysteroscopic Surgery, Tubal Surgeries, and others) And Others) among others.
- By Regions: North America, Asia Pacific, Europe, and the Rest-of-the-World.
Global Infertility Market - Regional Analysis
Well-developed regions such as North America and Europe, heading with their comparatively lower birth-rate account for the leading markets in the global infertility market. Also, various socioeconomic factors such as the financial support from the government for R&D in the field and R&D funding from private organizations to develop new techniques and technologies are predominantly increasing the size of the infertility market in these regions.
The US backed by the increasing pool of awareness, high income, and good reimbursement scenario accounts for the maximum market share in the North American infertility market. Whereas, countries such as the UK, Germany, and Canada are also expected to play an important role in the growth of this market.
North America holds a significantly larger share in the global infertility market, and, Europe is estimated to demonstrate high growth by the end of the forecast period, accounting for the second-largest market, globally.
The infertility market in the Asia Pacific region is quadrupling majorly due to the large technological advancements. Moreover, factors such as the rapid socio-ecological changes, the increasing number of working women populaces, and the rapidly improving economy are positively impacting the growth of the regional market. South Asian countries backed by the high rate of male infertility and the vast population with unmet needs are leading the APAC infertility market.
Global Infertility Market - Competitive Analysis
Highly competitive, the infertility market appears to be hugely fragmented with the presence of several large and small players. The key strategies traced from the analysis of recent market developments include agreement & partnership, product launch, acquisition, and expansion.
International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of technology portfolios, differentiation, quality, and pricing.
These key players are employing strategies of creating alliances with e-commerce partners and maintaining distribution agreements with strong local players in regions such as Western Europe and APEJ to consolidate their position.
Industry/Innovation/Related News:
- March 15, 2019 ---- A group from researchers from London presented their study of comparing the DNA integrity in infertile and fertile men, at the European Association of Urology Congress, held in Barcelona. These scientists have found that the DNA of sperm taken from the testicles of infertile men was as good as that of ejaculated sperm of fertile men.
- This research explains a major cause of male infertility and opens up the possibility of using sperm taken directly from the testicles to overcome infertility among males. Infertility is a major public health issue across Europe, and male infertility is the biggest cause in couples seeking treatment.
Related Report-
- Dental Surgical Devices Market Research Report- Global Forecast till 2027
- Osteoarthritis Market Research Report – Global Forecast Till 2027
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
